Company intelligence / Profile preview

Nextkidney

Ownership: Private
Development stage: Phase 1

Overview

Nextkidney has developed Neokidney, a portable home hemodialysis device. The device uses proprietary sorbent technology to minimize fluid requirements and maximize portability. As of early 2023–2024, the company was raising funds to support clinical trials and regulatory clearance in Europe and Singapore. No published pivotal clinical results yet.

Therapeutic areas: Nephrology
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Neokidney

Phase 1

Indications: End-stage kidney disease, Kidney failure

Partnerships

Debiotech SA (Switzerland) – technical partner/co-founder of joint venture

Beyond the preview

Go deeper on Nextkidney.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nextkidney.

Explore the full profile